Hellerup
Denmark
24
2026-03-19
11
2026-06-09
These are the the leading inventors for applications assigned to Bavarian Nordic A/S:
Bavarian Nordic A/S based in Hellerup, DK has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Mammalian Cell Line for the Production of Modified Vaccinia Virus Ankara (MVA)
#2 | 2025-12-25Recombinant Modified saRNA (VRP) and Vaccinia Virus Ankara (MVA) Prime-Boost Regimen
#3 | 2025-02-13Therapy for Modulating Immune Response with Recombinant MVA Encoding IL-12
#4 | 2025-01-02Combination Therapy for Treating Cancer with an Antibody and Intravenous Administration of a Recombinant MVA
#5 | 2024-11-28Utilization of Micro-RNA for Downregulation of Cytotoxic Transgene Expression by Modified Vaccinia Virus Ankara (MVA)
#6 | 2024-08-15Combination Therapy for Treating Cancer with an Intravenous Administration of a Recombinant MVA and an Immune Checkpoint Antagonist or Agonist
#7 | 2023-07-27A Recombinant Modified Vaccinia Virus (MVA) Vaccine Against Coronavirus Disease
#8 | 2023-06-22Recombinant MVA Viruses for Intratumoral and/or Intravenous Administration for Treating Cancer
#9 | 2023-04-13 ✅ Patent 12,648,992 granted on 2026-06-09Conditions Improving Poxvirus Stability
#10 | 2023-02-23Medical Uses of 4-1BBL Adjuvanted Recombinant Modified Vaccinia Virus Ankara (MVA)
#11 | 2022-08-11 ✅ Patent 11,723,964 granted on 2023-08-15Combination therapy for treating cancer with an antibody and intravenous administration of a recombinant MVA
#12 | 2022-01-06 ✅ Patent 12,390,515 granted on 2025-08-19Therapy for Treating Cancer with an Intratumoral or Intravenous Administration of a Recombinant MVA Encoding 4-1BBL (CD137L) and/or CD40L
#13 | 2021-12-23Recombinant Modified Vaccinia Virus Ankara (MVA) Foot and Mouth Disease Virus (FMDV) Vaccine
#14 | 2021-11-04 ✅ Patent 11,654,189 granted on 2023-05-23Compositions and methods for enhancing the stability of transgenes in poxviruses
#15 | 2021-09-30Methods and Compositions for Enhancing Vaccine Immune Responses
#16 | 2021-07-08 ✅ Patent 11,571,471 granted on 2023-02-07Recombinant modified vaccinia virus ankara (MVA) equine encephalitis virus vaccine
#17 | 2021-07-08Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist of an Immune Checkpoint Inhibitor
#18 | 2021-07-01Recombinant Modified Vaccinia Virus Ankara (MVA) Respiratory Syncytial Virus (RSV) Vaccine
#19 | 2021-06-24 ✅ Patent 12,150,988 granted on 2024-11-26Storage improved poxvirus compositions
#20 | 2020-10-15 ✅ Patent 12,644,125 granted on 2026-06-02Compositions and Methods for Inducing an Enhanced Immune Response Using Poxvirus Vectors
#21 | 2020-10-01 ✅ Patent 11,273,211 granted on 2022-03-15Combination therapy for treating cancer with an intravenous administration of a recombinant MVA and an antibody
#22 | 2020-08-27 ✅ Patent 11,338,030 granted on 2022-05-24Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding filovirus immunogens
#23 | 2020-06-04 ✅ Patent 10,946,089 granted on 2021-03-16Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine
#24 | 2018-08-02 ✅ Patent 11,753,652 granted on 2023-09-12Cassette encoding a FPV/brachyury fusion protein
Also check out Bavarian Nordic A/S's (Hellerup, Denmark) applicant profile with 13 patent applications submitted.
164166 ⎘